Healthcare provider profile · identity verified

Ranvir Sandhu, M.D.

Family Practice · ANTIOCH, CA · NPI 1508030461

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	403	135
Lisinopril	Lisinopril	268	89
Amlodipine Besylate	Amlodipine Besylate	218	74
Levothyroxine Sodium	Levothyroxine Sodium	148	44
Atenolol	Atenolol	145	45
Losartan Potassium	Losartan Potassium	143	48
Albuterol Sulfate Hfa	Albuterol Sulfate	133	54
Metoprolol Tartrate	Metoprolol Tartrate	124	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	123	21
Tamsulosin Hcl	Tamsulosin Hcl	115	37
Hydrochlorothiazide	Hydrochlorothiazide	112	35
Simvastatin	Simvastatin	109	37
Furosemide	Furosemide	100	29
Fluticasone Propionate	Fluticasone Propionate	87	39
Ibuprofen	Ibuprofen	85	35
Metformin Hcl	Metformin Hcl	85	33
Tizanidine Hcl	Tizanidine Hcl	85	30
Metoprolol Succinate	Metoprolol Succinate	76	24
Metformin Hcl Er	Metformin Hcl	72	27
Alendronate Sodium	Alendronate Sodium	71	25
Allopurinol	Allopurinol	71	24
Famotidine	Famotidine	67	25
Trazodone Hcl	Trazodone Hcl	67	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	21
Montelukast Sodium	Montelukast Sodium	63	21
Gabapentin	Gabapentin	61	27
Shingrix	Varicella-Zoster Ge/As01b/Pf	60	43
Hydroxyzine Hcl	Hydroxyzine Hcl	52	suppressed
Alvesco	Ciclesonide	50	27
Glipizide	Glipizide	49	19
Colchicine	Colchicine	45	12
Meloxicam	Meloxicam	45	16
Pantoprazole Sodium	Pantoprazole Sodium	45	13
Amoxicillin	Amoxicillin	44	13
Tramadol Hcl	Tramadol Hcl	44	suppressed
Carvedilol	Carvedilol	42	14
Citalopram Hbr	Citalopram Hydrobromide	42	16
Potassium Chloride	Potassium Chloride	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	12
Baclofen	Baclofen	34	suppressed
Omeprazole	Omeprazole	30	13
Temazepam	Temazepam	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Prednisone	Prednisone	28	20
Terazosin Hcl	Terazosin Hcl	28	suppressed
Lovastatin	Lovastatin	27	11
Azelastine Hcl	Azelastine Hcl	26	11
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	24	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Clonidine Hcl	Clonidine Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Nabumetone	Nabumetone	21	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	14
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Nifedipine Er	Nifedipine	18	suppressed
Mupirocin	Mupirocin	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Cefadroxil	Cefadroxil	16	11
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Naproxen	Naproxen	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error